#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Urethral valves Follicular lymphoma Chronic myelomonocytic leukaemia Immune thrombocytopenia Pituitary-dependent Cushing's syndrome Cerebral arteriovenous malformation haemorrhagic Synovial sarcoma recurrent Neuroendocrine carcinoma of the skin Palmoplantar pustulosis Chondrosarcoma metastatic Hepatic cirrhosis Alagille syndrome Complex regional pain syndrome Primary amyloidosis Transferrin decreased More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Life with Disease Inclusion body myositis – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Idiopathic pulmonary fibrosis – Basic Information Osteosarcoma – Basic Information Congenital nephrogenic diabetes insipidus – Diagnostics Angelman’s syndrome – Life with Disease Cystic fibrosis lung – Basic Information Myelodysplastic syndrome – Diagnostics Carcinoid syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Colecalciferol Naxitamab Nazartinib Fluconazole ATOVAQUONE ATTR-01 Nebivolol Carbamazepine (Ph. Eur.) Ponesimod Clobetasol Binimetinib Phenylephrine Hydrochloride Ianalumab 19Cp02 Somapacitan Alkaline Phosphatase, Bovine Abacavir Paliperidone Losartan Dabrafenib More therapies…

    Learn about Your Condition

    Cystic fibrosis lung Cardiomyopathy Tubulointerstitial nephritis Ophthalmoplegia Peritoneal abscess Schizophreniform disorder Candida infection Polycystic ovarian syndrome Labour induction Acne Angiosarcoma recurrent Electrocorticogram Coronary artery occlusion Liver transplant rejection Anogenital warts More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Long-term safety and effectiveness study of leniolisib for patients with primary immunodeficiency and immune system problems

    Recruiting

    2 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Leniolisib Phosphate
    Spain

  • Study of nivolumab and ipilimumab immunotherapy for organ preservation in patients with advanced head and neck squamous cell carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • A Study of Pacritinib for Reducing Bone Marrow Scarring in Patients with Myelofibrosis Who Have Low Platelet Counts

    Recruiting

    2 1 1
    Investigated Drugs:
    • Pacritinib
    Spain

  • Study of SAT-3247 Compared to Placebo for Patients with Duchenne Muscular Dystrophy Who Can Walk

    Recruiting

    2 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • SAT-3247 OXALATE
    Belgium Poland Spain

  • Study of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma metastatic
    Investigated Drugs:
    • Gemcitabine
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Ireland +5

  • A Study of Intravenous Ferric Carboxymaltose on Quality of Life in Older Adults with Acute Coronary Syndrome and Iron Deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Ferric Carboxymaltose
    Spain
Previous Page
1 … 83 84 85 86 87 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!